Healthcare organizations using AI must comply with HIPAA's minimum necessary standard, ensure Business Associate Agreements with AI vendors, and maintain audit trails of all AI usage involving patient data.
As AI adoption accelerates across hospitals, health systems, and payer organizations, governance frameworks must address clinical safety, patient privacy, and regulatory requirements unique to healthcare. Without structured AI governance, healthcare organizations risk HIPAA violations, patient harm, and loss of trust.
Why AI Governance Is Different for Healthcare
Healthcare operates under some of the most stringent data protection and safety regulations of any industry. When AI enters the clinical or administrative workflow, it intersects with HIPAA, FDA oversight for clinical decision support, state privacy laws, and professional licensing requirements.
Unlike other industries where AI errors may result in financial loss or reputational damage, AI failures in healthcare can directly harm patients. A diagnostic AI that produces a false negative, a medication dosing tool that hallucinates a recommendation, or a scheduling system that leaks Protected Health Information (PHI) all carry consequences that extend far beyond fines.
Healthcare AI governance must account for several unique factors:
- PHI sensitivity: Patient data is among the most regulated data categories globally. Any AI tool that processes, stores, or transmits PHI must meet HIPAA Security Rule and Privacy Rule requirements.
- Clinical safety: AI used in clinical decision-making may be classified as a medical device by the FDA, triggering additional regulatory oversight under the 21st Century Cures Act and FDA guidance on Clinical Decision Support software.
- Multi-stakeholder environment: Physicians, nurses, administrators, IT teams, and compliance officers all interact with AI differently, requiring role-based governance policies.
- Interoperability requirements: Healthcare AI often integrates with EHR systems, health information exchanges, and third-party platforms, expanding the data governance surface area.
Building on the foundational concepts covered in our complete AI policy and governance guide, healthcare organizations need to layer industry-specific controls on top of general best practices.
The Top AI Risks Facing Healthcare Organizations
Healthcare organizations face a distinct set of AI risks that demand proactive identification and mitigation. The following table summarizes the highest-priority risks:
| Risk | Likelihood | Impact | Mitigation |
|---|---|---|---|
| PHI entered into consumer AI tools | High | Critical | Block consumer AI at the network level; deploy approved enterprise AI tools with BAAs; train all staff on PHI handling with AI |
| Clinical AI used without physician oversight | Medium | Critical | Require human-in-the-loop for all clinical AI outputs; document oversight protocols; maintain audit logs of clinical AI use |
| Staff using free AI tools for patient communications | High | High | Provide sanctioned alternatives for drafting patient communications; monitor for shadow AI usage; include AI in onboarding training |
| AI vendor without Business Associate Agreement | Medium | High | Require BAAs for all AI vendors processing PHI; maintain a vendor registry; conduct annual vendor risk assessments |
Each of these risks requires a layered mitigation strategy that combines technical controls, policy enforcement, and staff education. Shadow AI is a particularly acute challenge in healthcare settings where clinicians adopt tools to save time without understanding the compliance implications. Our guide on building AI audit trails covers the monitoring infrastructure needed to detect unauthorized usage.
What Regulators and Auditors Expect
Healthcare regulators are increasingly focused on AI governance. The HHS Office for Civil Rights (OCR) has signaled that HIPAA enforcement will extend to AI tool usage, and the Office of the National Coordinator for Health IT (ONC) has issued guidance on the responsible use of AI in health IT systems.
Key regulatory expectations include:
- Documented AI inventory: Regulators expect a current inventory of all AI tools in use, including which tools process PHI and what safeguards are in place.
- Business Associate Agreements: Any AI vendor that creates, receives, maintains, or transmits PHI must have a signed BAA. This includes large language model providers, transcription services, and analytics platforms.
- Risk assessments: HIPAA requires periodic risk assessments. AI tools must be included in these assessments, evaluating threats to the confidentiality, integrity, and availability of PHI.
- Minimum necessary standard: AI tools should only access the minimum amount of PHI necessary to perform their function. Broad access to patient records for AI training or inference is a red flag.
- Breach notification readiness: If an AI tool causes or contributes to a data breach, the organization must be prepared to notify affected individuals, HHS, and potentially the media within the required timeframes.
Joint Commission surveyors and CMS auditors are also beginning to ask about AI governance during accreditation reviews. Organizations that cannot demonstrate a structured governance program risk findings that affect their accreditation status.
AI Governance Built for Healthcare Teams
PolicyGuard helps healthcare organizations enforce AI policies, detect shadow AI usage, and generate audit documentation regulators want to see.
Start free trialPolicyGuard helps companies like yours get AI governance documentation audit-ready in 48 hours or less.
Start free trial →Building an AI Policy for Healthcare Teams
A healthcare AI policy must address the unique regulatory and clinical environment while remaining practical enough for busy clinical and administrative staff to follow. Start with our AI acceptable use policy template and customize it with the following healthcare-specific sections:
PHI and Data Classification
Define what constitutes PHI in the context of AI usage and establish clear rules for which data categories may and may not be entered into AI tools. Create a tiered classification system:
- Prohibited: Direct patient identifiers, medical record numbers, Social Security numbers, and complete clinical notes must never be entered into any AI tool without explicit approval and a BAA in place.
- Restricted: De-identified clinical data, aggregate statistics, and operational metrics may be used with approved AI tools that meet organizational security requirements.
- Permitted: General medical knowledge queries, administrative workflows without patient data, and educational use cases may use approved AI tools following standard guidelines.
Clinical AI Decision Support
Establish protocols for AI used in clinical decision-making. Every clinical AI output must be reviewed by a licensed clinician before acting on it. Document the physician override process and ensure that AI recommendations are recorded in the medical record alongside the clinician's independent assessment.
Vendor and Tool Approval
Create a formal approval process for new AI tools. Require security assessments, BAA execution, and compliance review before any AI tool is deployed. Maintain an approved tool registry that staff can reference. This process should align with your broader governance framework.
How to Monitor and Enforce AI Usage in Healthcare
Monitoring AI usage in healthcare requires a combination of technical controls and cultural practices. Given the high stakes of PHI exposure and clinical safety, healthcare organizations should invest in robust monitoring infrastructure.
Technical Controls
- Network-level blocking: Block access to unapproved AI tools at the firewall and proxy level. This prevents staff from using consumer AI products that lack BAAs or appropriate security controls.
- DLP integration: Deploy data loss prevention tools that detect PHI patterns (medical record numbers, diagnosis codes, patient names) in outbound traffic to AI services.
- Endpoint monitoring: Use endpoint detection tools to identify AI applications installed on workstations and mobile devices. Browser extensions that interact with AI services should be specifically monitored.
- EHR audit logs: Review EHR audit logs for unusual data export patterns that might indicate copy-paste workflows from the EHR into external AI tools.
Policy Enforcement
Technical controls alone are insufficient. Healthcare organizations must build a culture of AI compliance through regular training, clear consequences for policy violations, and accessible channels for staff to request new AI tools. Consider appointing department-level AI liaisons who can help colleagues find approved solutions for their workflow challenges.
PolicyGuard provides automated monitoring and enforcement tools designed specifically for organizations managing AI risk at scale. Combined with our policy templates, healthcare teams can stand up a comprehensive governance program in weeks rather than months.
Frequently Asked Questions
Can healthcare workers use ChatGPT or other consumer AI tools?
Healthcare workers should not use consumer AI tools for any task involving PHI or patient-related information. Consumer AI products typically do not have Business Associate Agreements, do not meet HIPAA Security Rule requirements, and may use input data for model training. Organizations should provide approved enterprise AI alternatives and block access to consumer tools on clinical networks.
Do we need a BAA with every AI vendor?
A BAA is required with any AI vendor that creates, receives, maintains, or transmits PHI on behalf of your organization. This includes AI transcription services, clinical decision support tools, administrative AI platforms that process patient scheduling data, and analytics tools that access clinical data. If the AI tool never touches PHI, a BAA may not be required, but you should document that determination.
Is clinical AI regulated by the FDA?
Some clinical AI is regulated by the FDA. AI tools that are intended to diagnose, treat, cure, mitigate, or prevent disease may be classified as medical devices. However, the 21st Century Cures Act exempts certain Clinical Decision Support (CDS) software from device regulation if it meets specific criteria, including that the clinician independently reviews the basis of the recommendation. Organizations should consult with regulatory counsel to determine whether their clinical AI tools fall under FDA oversight.
How often should we conduct AI risk assessments in healthcare?
AI risk assessments should be conducted at least annually as part of your HIPAA-required security risk assessment. However, additional assessments should be triggered whenever a new AI tool is deployed, an existing tool is updated significantly, a security incident involving AI occurs, or regulatory guidance changes. Continuous monitoring through audit trail systems supplements periodic formal assessments.
What should we include in AI training for clinical staff?
AI training for clinical staff should cover: which AI tools are approved and how to access them, what data can and cannot be entered into AI tools, how to evaluate AI outputs critically before acting on them, how to report suspected AI errors or misuse, the organization's incident response process for AI-related events, and relevant regulatory requirements including HIPAA obligations. Training should be role-specific and refreshed at least annually.
